CXCR4 and breast carcinoma: Interestingly, Fritsche et al. revealed that a knockdown of the pro-apoptotic TNF-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) reduces pAKT and CXCR4 levels in breast cancer cells and leads to reduced bone metastasis in vivo [65].